Printer Friendly

CROP GENETICS INTERNATIONAL REPORTS RESULTS FOR QUARTER ENDING MARCH 31, 1993

 HANOVER, Md., May 7 /PRNewswire/ -- Crop Genetics International (NASDAQ: CROP) today reported revenues of $726,500 for the quarter ended March 31, 1993, compared to $620,400 in the same quarter last year.
 Net loss was $1,719,300 or $.29 per share, compared to a net loss of $1,652,900 or $.43 per share in the same quarter of last year. The average number of common shares outstanding at March 31, 1993, was 8,191,799 compared to 5,363,128 at March 31, 1992.
 The increase in net loss was directly related to the company's plans to move in May into a newly leased and renovated production and laboratory facility. "Moving has required us to accelerate the depreciation of our existing leasehold improvements as well as incur numerous premove expenses," said Mac McGuire, director of finance of Crop Genetics International.
 Crop Genetics International Corporation develops biological crop protection systems to control insects, weeds and other agricultural pests. The company's research is focused on creation of unique pesticides that are both effective for food production and compatible with the environment. The company's InStar(TM) Division, in cooperation with DuPont, is developing insecticidal virus products to control a range of insect pests on major crops. The Incide(R) Division is developing plant vaccine systems in which plant seeds are inoculated with genetically engineered micro-organisms to provide season-long pest control. The X-tend(TM) Division is developing bacterial agents to control a broad range of weed species. The Kleentek(R) Division has developed and now markets disease-free, high-yielding sugarcane seed products.
 CROP GENETICS INTERNATIONAL CORPORATION
 Condensed Statements of Operations
 Three months ending March 31 1993 1992
 Revenues:
 Research revenue $500,000 $437,500
 Investment income 224,400 162,700
 Other 2,100 20,200
 Total revenues 726,500 620,400
 Costs and expenses:
 Field management 130,900 117,100
 Research and development 1,867,300 1,653,500
 General and administrative 447,600 464,000
 Acquired technology --- 38,700
 Total costs and expenses 2,445,800 2,273,300
 Net loss (1,719,300) (1,652,900)
 Preferred stock dividends 640,100 640,100
 Net loss applicable
 to common shares (2,359,400) (2,293,000)
 Net loss per common share ($.29) ($.43)
 Average number of common
 shares outstanding 8,191,799 5,363,128
 Condensed Balance Sheets
 March 31, 1991 Dec. 31, 1992
 Current assets:
 Cash and short-term investments $17,997,900 $20,971,300
 Other current assets 1,128,900 1,150,500
 Total current assets 19,126,800 22,121,800
 Fixed assets (net) 2,815,400 2,131,100
 Total 21,942,200 24,252,900
 Current liabilities 506,100 500,200
 Common and preferred stockholders'
 equity 21,436,100 23,752,700
 Total 21,942,200 24,252,900
 -0- 5/7/93
 /CONTACT: Charles C. McGuire III, director of finance of Crop Genetics International, 410-712-7170, or Anthony J. Russo, Ph.D. of Noonan/Russo Communications, 212-979-9180, for Crop Genetics International/
 (CROP)


CO: Crop Genetics International Corporation ST: Maryland IN: SU: ERN

MK-SF -- PH035 -- 6144 05/07/93 17:15 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 7, 1993
Words:515
Previous Article:WISCONSIN PHARMACAL COMPANY, INC. REPORTS SECOND QUARTER OPERATING RESULTS
Next Article:BIG SKY USA ANNOUNCES DEVELOPMENT OF ORGANIK, A 100-PERCENT COTTON, NO-SHRINK JERSEY FABRIC
Topics:


Related Articles
CROP GENETICS INTERNATIONAL REPORTS RESULTS FOR QUARTER ENDED MARCH 31, 1992
CROP GENETICS REPORTS IMPROVED CONTROL WITH CORN BIOINSECTICIDE
DEKALB AND CROP GENETICS MODIFY AGREEMENT
MORTON INTERNATIONAL REPORTS RECORD THIRD QUARTER
CROP GENETICS INTERNATIONAL RECEIVES EPA REGISTRATION
MYCOGEN REPORTS HIGHER FIRST QUARTER EARNINGS
ECOGEN REPORTS RECORD REVENUES IN FIRST QUARTER AND A SIGNIFICANT REDUCTION OF NET LOSS
CROP GENETICS INTERNATIONAL DECLARES PREFERRED STOCK DIVIDENDS
CROP GENETICS INTERNATIONAL CANCELS MARKETING AGREEMENT
BIOSYS INC. ANNOUNCES FOURTH QUARTER RESULTS

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters